← The Wire
FLGTNasdaq
Fulgent Genetics, Inc.
Services-Medical Laboratories · DE · CIK 1674930
Fulgent Genetics provides laboratory testing services and develops cancer therapeutics using a nanoencapsulation platform
red 8-K · 90d
$531M
Market cap
$20.53
Last close
+2.9%
1D
+15.1%
5D
295K
Volume
Price · last 39 sessions+35.8%
May 4L $14.90 · H $20.53Jun 29
150
Total filings
Jun 2, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 2, 2026SC 13D/ASC 13D/AMay 27, 20268-KCompany UpdateMay 21, 20268-KExecutive Change · Shareholder VoteMay 14, 202610-Q10-QMay 1, 20268-KResults of Operations · Reg FD DisclosureMay 1, 2026DEFA14ADEFA14AMar 31, 2026DEF 14ADEF 14AMar 31, 2026SC 13D/ASC 13D/AMar 31, 20268-KMaterial Agreement · Acquisition / DispositionMar 17, 202610-K10-KFeb 27, 20268-KResults of Operations · Reg FD DisclosureFeb 27, 20268-KMaterial Agreement · Company UpdateDec 22, 202510-Q10-QNov 7, 20258-KResults of Operations · Reg FD DisclosureNov 7, 20258-KCompany UpdateOct 20, 202510-Q10-QAug 1, 20258-KResults of Operations · Reg FD DisclosureAug 1, 20258-KShareholder VoteMay 15, 202510-Q10-QMay 2, 20258-KResults of Operations · Reg FD DisclosureMay 2, 2025DEFA14ADEFA14AMar 26, 2025DEF 14ADEF 14AMar 25, 202510-K10-KFeb 28, 20258-KResults of Operations · Reg FD DisclosureFeb 28, 202510-Q10-QNov 8, 20248-KResults of Operations · Reg FD DisclosureNov 8, 202410-Q10-QAug 2, 20248-KResults of Operations · Reg FD DisclosureAug 2, 20248-KShareholder VoteMay 16, 202410-Q10-QMay 3, 20248-KResults of Operations · Reg FD DisclosureMay 3, 2024DEFA14ADEFA14AMar 27, 2024DEF 14ADEF 14AMar 27, 202410-K10-KFeb 28, 20248-KResults of Operations · Reg FD DisclosureFeb 28, 202410-Q10-QNov 3, 20238-KResults of Operations · Reg FD DisclosureNov 3, 202310-Q10-QAug 4, 20238-KResults of Operations · Reg FD DisclosureAug 4, 20238-KExecutive Change · Shareholder VoteMay 18, 202310-Q10-QMay 5, 20238-KResults of Operations · Reg FD DisclosureMay 5, 2023DEFA14ADEFA14AApr 3, 2023DEFA14ADEFA14AMar 31, 2023DEF 14ADEF 14AMar 31, 202310-K10-KFeb 28, 20238-KResults of Operations · Reg FD DisclosureFeb 28, 2023SC 13GSC 13GJan 20, 20238-KMaterial AgreementJan 12, 20238-KExecutive Change · Company UpdateJan 3, 20238-KDelisting NoticeNov 23, 202210-Q10-QNov 7, 20228-KResults of Operations · Reg FD DisclosureNov 7, 20228-KExecutive ChangeNov 4, 20228-KExecutive ChangeSep 29, 202210-Q10-QAug 4, 20228-KResults of Operations · Reg FD DisclosureAug 4, 20228-KExecutive ChangeJun 30, 20228-KShareholder VoteMay 19, 202210-Q10-QMay 5, 20228-KResults of Operations · Reg FD DisclosureMay 3, 20228-KAcquisition / DispositionApr 26, 20228-KMaterial Agreement · Results of OperationsApr 18, 2022DEF 14ADEF 14AMar 29, 20228-KExecutive ChangeMar 29, 202210-K10-KFeb 28, 20228-KResults of Operations · Reg FD DisclosureFeb 23, 202210-Q10-QNov 9, 20218-KResults of Operations · Reg FD DisclosureNov 9, 202110-Q10-QAug 10, 20218-KResults of Operations · Reg FD DisclosureAug 9, 20218-KShareholder VoteMay 20, 202110-Q10-QMay 7, 20218-KResults of OperationsMay 6, 2021DEFA14ADEFA14AApr 1, 2021DEF 14ADEF 14AApr 1, 202110-K10-KMar 8, 20218-KResults of OperationsMar 4, 20218-KMaterial AgreementFeb 5, 2021
Insider Activity
In the 90 days to Dec 2, 2025: 2 sold $454K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 2, 2025 | Xie JianPresident and COO | Sell | 1,140 | $28.33 | $32K |
| Dec 2, 2025 | Gao HanlinChief Scientific Officer | Sell | 1,075 | $28.33 | $30K |
| Nov 28, 2025 | Xie JianPresident and COO | Sell | 1,198 | $29.57 | $35K |
| Nov 28, 2025 | Gao HanlinChief Scientific Officer | Sell | 943 | $29.57 | $28K |
| Nov 24, 2025 | Xie JianPresident and COO | Sell | 681 | $30.47 | $21K |
| Nov 24, 2025 | Gao HanlinChief Scientific Officer | Sell | 535 | $30.47 | $16K |
| Nov 19, 2025 | Xie JianPresident and COO | Sell | 10,000 | $29.10 | $291K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance